@asarinapharma.com
Asarina Pharma is a company targeted on developing products to treat women with severe symptoms associated with the menstrual cycle.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Asarina Pharma is a pioneering brand that is focused on developing innovative treatments for a wide range of stress- and compulsion-related conditions. Their groundbreaking product, Sepranolone, is a novel treatment that targets the powerful neurosteroid Allopregnanolone, which is implicated in disorders such as Tourette syndrome, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). Sepranolone is the first in a new family of GABA A Modulating Steroid Antagonists (GAMSAs), which inhibit and modulate ALLO, offering a new paradigm shift in the treatment of these conditions.
With a highly experienced management team, Asarina Pharma brings together expertise from the pharmaceutical industry and venture capital field. Led by CEO and CMO Peter Nordkild, who has extensive experience in pharmaceutical companies, they are dedicated to bringing safe, natural, and effective compounds to the market. The team also includes a Director of CMC, a Senior Consultant, a Chief Financial Officer, and a Chief Business Officer, all of whom bring a wealth of experience and knowledge to the company.
Asarina Pharma's Board of Directors consists of individuals with decades of combined experience in pharmaceutical development and commercialization. The international team reflects the global potential of their therapies and includes experts from various countries. The Chairman of the board, Paul de Potocki, has comprehensive experience in corporate leadership and financial management in the life sciences industry.
Erin Gainer, Director of the Board, is a global leader in women's health pharmaceuticals and has led the development of innovative products in this field. Marianne Kock, also a Director of the Board, brings extensive experience in R&D, clinical development, and regulatory affairs. Overall, Asarina Pharma is at the forefront of developing groundbreaking treatments for stress- and compulsion-related conditions, and their team of experts is dedicated to driving innovation and bringing these much-needed therapies to patients worldwide
Company Type
Privately Held
Company Size
2-10
Year Founded
2006
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories